Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Otol Neurotol ; 40(9): e894-e900, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31498289

RESUMO

OBJECTIVE: To evaluate the clinical feasibility and auditory benefits of hearing rehabilitation using electroacoustic stimulation (EAS) after cochlear implantation (CI) and to identify the predictive factors for successful EAS rehabilitation in children with limited low-frequency hearing. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral hospital. PATIENTS: Seventeen children (21 ears) under the age of 15 years with residual low-frequency hearing who underwent CI using hearing preservation techniques. INTERVENTION: Patients underwent CI using hearing preservation techniques, and the postoperative audiograms were obtained to evaluate the hearing preservation rate. EAS rehabilitation was applied in patients with successful low-frequency hearing preservation. OUTCOME MEASURES: Improvements in speech perception in both quiet and noise conditions were compared between the EAS mode and the CI-only mode. The predictive factors for successful EAS rehabilitation in children were analyzed. RESULTS: Functional low-frequency residual hearing less than or equal to 85 dB at 250 and 500 Hz was achieved postoperatively in six of 21 ears, and successful EAS rehabilitation was possible in nine of 21 ears. Better speech perception scores were observed in quiet conditions using the EAS mode compared with the CI-only mode, although the difference did not reach statistical significance. Significantly, better scores were observed in noise conditions with the EAS mode compared with the CI-only mode. Postoperative low-frequency pure-tone average was the only significant predictive factor of successful EAS rehabilitation. CONCLUSION: CI surgery using hearing preservation techniques with EAS rehabilitation should be performed in children, even in patients with limited residual hearing, to improve auditory outcomes.


Assuntos
Implante Coclear/métodos , Implantes Cocleares , Perda Auditiva Neurossensorial/reabilitação , Audição/fisiologia , Percepção da Fala/fisiologia , Estimulação Acústica/métodos , Adolescente , Limiar Auditivo/fisiologia , Criança , Pré-Escolar , Progressão da Doença , Feminino , Perda Auditiva Neurossensorial/cirurgia , Testes Auditivos , Humanos , Masculino , Período Pós-Operatório , Prognóstico , Estudos Retrospectivos , Centros de Atenção Terciária , Resultado do Tratamento
2.
Eur J Cancer ; 42(18): 3260-6, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17045795

RESUMO

In recent studies, green tea components have been shown to induce cell growth arrest and apoptosis in head and neck squamous cell carcinoma (HNSCC) cells. In this report, we have investigated the effects of epicatechin gallate (ECG), one of the catechins in green tea, on anti-cancer activity in vitro. We found that cyclin D1 was highly expressed in HNSCC cells, and ECG suppressed 90% of cyclin D1 expression in SCC7 cells. We have also evaluated the effect of ECG on cell growth and apoptosis, showing that ECG (50 microM) exhibited a significant inhibition (50%) on the growth of SCC7 cells via G1 cell cycle arrest. ECG suppressed cyclin D1 in SCC7 cells in a dose- and time-dependent manner, and the suppression of the beta-catenin pathway by ECG is one of the mechanism to facilitate ECG-induced cell growth arrest. These results suggest that ECG has a potential usage as a chemopreventive agent in HNSCC.


Assuntos
Antineoplásicos/uso terapêutico , Carcinoma de Células Escamosas/patologia , Catequina/análogos & derivados , Ciclina D1/metabolismo , Inibidores do Crescimento/uso terapêutico , Neoplasias de Cabeça e Pescoço/patologia , Proteínas de Neoplasias/metabolismo , Apoptose/efeitos dos fármacos , Carcinoma de Células Escamosas/tratamento farmacológico , Catequina/uso terapêutico , Linhagem Celular Tumoral , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Citocinas/metabolismo , Flavonoides/farmacologia , Citometria de Fluxo , Fator 15 de Diferenciação de Crescimento , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Humanos , Fenóis/farmacologia , Polifenóis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA